Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,347 | 2,986 | -781 | -2,545 | -4,311 |
| Depreciation Amortization | N/A | N/A | N/A | 851 | 1,611 |
| Accounts payable and accrued liabilities | -21 | N/A | -157 | -101 | -117 |
| Other Working Capital | -50 | -8 | 52 | -220 | -16 |
| Other Operating Activity | 510 | -3,794 | -239 | 283 | 972 |
| Operating Cash Flow | $-908 | $-816 | $-1,125 | $-1,732 | $-1,861 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,020 | 704 | -2,500 | N/A | N/A |
| PPE Investments | -2 | N/A | 1 | -2 | -2 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -64 | -64 |
| Other Investing Activity | 93 | 74 | 4 | -64 | -108 |
| Investing Cash Flow | $2,111 | $778 | $-2,495 | $-66 | $-110 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 4,892 | N/A | 3,579 |
| Financing Cash Flow | $N/A | $N/A | $4,892 | $N/A | $3,579 |
| Exchange Rate Effect | -3 | 4 | -2 | N/A | -2 |
| Beginning Cash Position | 3,255 | 3,289 | 2,019 | 3,817 | 2,159 |
| End Cash Position | 4,455 | 3,255 | 3,289 | 2,019 | 3,817 |
| Net Cash Flow | $1,200 | $-34 | $1,270 | $-1,798 | $1,658 |
| Free Cash Flow | |||||
| Operating Cash Flow | -908 | -816 | -1,125 | -1,732 | -1,861 |
| Capital Expenditure | -2 | N/A | N/A | -2 | -2 |
| Free Cash Flow | -910 | -816 | -1,125 | -1,734 | -1,863 |